KX2-391 is the first clinical Src inhibitor (peptidoid) targeting a peptide substrate site of Src with GI50 of 9-60 nM in cancer cell lines. Phase 2.

 

Brand: BCM

 

Boiling Point: 680.9±55.0 °C at 760 mmHg

 

Flashing Point: 365.6±31.5 °C

 

Solubility: Soluble in DMSO. Insoluble in Water and Ethanol.

 

Attribute
[CAS No.]	897016-82-9
[Formula]	C26H29N3O3
[Molecular]	431.5268
[Chem Name]	N-Benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
[Synonym]	KX2-391; Tirbanibulin
[Storage]	Sealed in dry,Store in freezer, under -20°C
[EINECS]	200-258-5
[MDL No.]	MFCD18633218
[Form]	Powder

Goods Tag